<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03458468</url>
  </required_header>
  <id_info>
    <org_study_id>SSC-Latarjet-001</org_study_id>
    <nct_id>NCT03458468</nct_id>
  </id_info>
  <brief_title>Tranexamic Acid for the Latarjet Procedure.</brief_title>
  <official_title>A Randomised, Prospective Evaluation on the Effectiveness of Tranexamic Acid in Reducing Postoperative Swelling and Haematoma Formation After the Latarjet Procedure.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sports Surgery Clinic, Santry, Dublin</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sports Surgery Clinic, Santry, Dublin</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The investigators propose a double-blinded randomized study evaluating the effectiveness of
      tranexamic acid in reducing postoperative swelling and haematoma formation after the Latarjet
      procedure.

      The purpose of this study is to assess the efficacy of tranexamic acid (TXA), given via
      intra-articular injection at the time of surgery in patients undergoing the Latarjet
      procedure for shoulder instability.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">March 2018</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>Double-blinded randomized</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Hematoma Formation</measure>
    <time_frame>Postoperative day-1</time_frame>
    <description>Patients hematoma formation will be evaluated using the Pauzenberger criteria (Grade 1-4)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>Postoperative day-1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Total Drain output</measure>
    <time_frame>Postoperative day-1</time_frame>
    <description>The total drain output of blood post-operatively</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Opioid consumption</measure>
    <time_frame>Postoperative day-1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Wound complications</measure>
    <time_frame>Postoperative week-2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Graft position on X-ray</measure>
    <time_frame>Postoperative week 2, month-4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>Postoperative month-4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Persistent Shoulder Apprehension</measure>
    <time_frame>Postoperative month-4</time_frame>
    <description>Persistent shoulder apprehension, i.e. continued perception of shoulder instability will be assessed.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Total complications</measure>
    <time_frame>Postoperative month-4</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Haematoma Formation</measure>
    <time_frame>Postoperative week-2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>Postoperative week-2</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Visual Analogue Scale</measure>
    <time_frame>Postoperative week-16</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Anterior Shoulder Instability</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Tranexamic Acid 1g IV</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Saline injection</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tranexamic Acid</intervention_name>
    <description>1g Tranexamic acid prior to skin incision</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Saline</intervention_name>
    <description>Equivalent volume of saline prior to skin incision</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        â€¢ Anterior shoulder instability, warranting the Latarjet procedure

        Exclusion Criteria:

          -  Patients with known risk factors for hyper-coagulable state

          -  Patients under 16

          -  Patients unable to give consent to partake in the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hannan Mullett, FRCSI</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sports Surgery Clinic</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Daren Lim Fat, FEBOT</last_name>
    <phone>+353 1 526 2251</phone>
    <email>darenlimfat@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Sports Surgery Clinic</name>
      <address>
        <city>Santry</city>
        <state>Dublin</state>
        <zip>9</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Hannan Mullett, FRCSI</last_name>
      <phone>+353 1 526 2251</phone>
      <email>hannanmullett@me.com</email>
    </contact>
    <contact_backup>
      <last_name>Daren Lim Fat, FEBOT</last_name>
      <phone>+353 1 526 2251</phone>
      <email>darenlimfat@yahoo.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <reference>
    <citation>Gillespie R, Shishani Y, Joseph S, Streit JJ, Gobezie R. Neer Award 2015: A randomized, prospective evaluation on the effectiveness of tranexamic acid in reducing blood loss after total shoulder arthroplasty. J Shoulder Elbow Surg. 2015 Nov;24(11):1679-84. doi: 10.1016/j.jse.2015.07.029.</citation>
    <PMID>26480877</PMID>
  </reference>
  <reference>
    <citation>Pauzenberger L, Domej MA, Heuberer PR, Hexel M, Grieb A, Laky B, Blasl J, Anderl W. The effect of intravenous tranexamic acid on blood loss and early post-operative pain in total shoulder arthroplasty. Bone Joint J. 2017 Aug;99-B(8):1073-1079. doi: 10.1302/0301-620X.99B8.BJJ-2016-1205.R1.</citation>
    <PMID>28768785</PMID>
  </reference>
  <reference>
    <citation>Vara AD, Koueiter DM, Pinkas DE, Gowda A, Wiater BP, Wiater JM. Intravenous tranexamic acid reduces total blood loss in reverse total shoulder arthroplasty: a prospective, double-blinded, randomized, controlled trial. J Shoulder Elbow Surg. 2017 Aug;26(8):1383-1389. doi: 10.1016/j.jse.2017.01.005. Epub 2017 Feb 3.</citation>
    <PMID>28162887</PMID>
  </reference>
  <reference>
    <citation>Kirsch JM, Bedi A, Horner N, Wiater JM, Pauzenberger L, Koueiter DM, Miller BS, Bhandari M, Khan M. Tranexamic Acid in Shoulder Arthroplasty: A Systematic Review and Meta-Analysis. JBJS Rev. 2017 Sep;5(9):e3. doi: 10.2106/JBJS.RVW.17.00021.</citation>
    <PMID>28902659</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2018</study_first_submitted>
  <study_first_submitted_qc>March 1, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 8, 2018</study_first_posted>
  <last_update_submitted>March 1, 2018</last_update_submitted>
  <last_update_submitted_qc>March 1, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 8, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>tranexamic acid</keyword>
  <keyword>anterior shoulder instability</keyword>
  <keyword>latarjet</keyword>
  <keyword>hematoma</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tranexamic Acid</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

